Journal Home
Search for

Volume 33, Issue 6, Pages 971-977 (June 2007)


View previous. 25 of 57 View next.

One-year results of photorefractive keratectomy and laser in situ keratomileusis for myopia using a 213 nm wavelength solid-state laser

Nikolaos S. Tsiklis, MD, MScCorresponding Author Informationemail address, George D. Kymionis, MD, PhD, George A. Kounis, Aristofanis I. Pallikaris, MSc, Vasilios F. Diakonis, MD, Spyridon Charisis, MD, Marinos M. Markomanolakis, MD, Ioannis G. Pallikaris, MD, PhD

Accepted 27 February 2007.

Purpose

To study the long-term results of photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) in low to moderate myopic corrections using the Pulzar Z1 system (CustomVis), a 213 nm wavelength solid-state laser.

Setting

University refractive surgery center.

Methods

This prospective noncomparative case series comprised 20 patients (40 eyes) who had refractive surgery using the Pulzar Z1 laser system. Manifest refraction, uncorrected visual acuity, best spectacle-corrected visual acuity (BSCVA), safety, predictability, stability, and confocal microscopy images were evaluated.

Results

Ten patients (20 eyes) had PRK and 10 patients (20 eyes) had LASIK. The mean follow-up was 13.9 months ± 1.1 (SD) (range 12 to 17 months) and 14.6 ± 1.2 months (range 12 to 18 months) in the PRK group and LASIK group, respectively. No eye lost a line of Snellen BSCVA during the follow-up period; 2 eyes (10%) gained 2 Snellen lines. There was a statistically significant decrease in spherical equivalent manifest refraction postoperatively in both groups (P<.05). Refractive stability was obtained during the first postoperative month and remained stable during the follow-up period, with no significant changes between any interval in both groups (P>.05). At the last follow-up, 95% of all eyes were within ±1.00 diopter of emmetropia. No late postoperative complications were observed.

Conclusion

Refractive surgery using the Pulzar Z1 213 nm wavelength solid-state laser was a safe, effective procedure in the treatment of low to moderate myopia.

From the Department of Ophthalmology (Tsiklis, Kymionis, Charisis, I.G. Pallikaris) and Institute of Vision and Optics (Tsiklis, Kymionis, Kounis, A.I. Pallikaris, Diakonis, Markomanolakis, I.G. Pallikaris), University of Crete, Crete, Greece

Corresponding Author InformationCorresponding author: Nikolaos S. Tsiklis, MD, MSc, Institute of Vision and Optics, University of Crete, Medical School Department of Ophthalmology, 71003 Heraklion, Crete, Greece.

 No author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(07)00487-7

doi:10.1016/j.jcrs.2007.02.033


View previous. 25 of 57 View next.